Uphando ngoMatshi ka-2022 kwi-JNCCN-Journal ye-National Comprehensive Cancer Network ihlolisise idatha evela kwi-Ontario Cancer Registry ukususela ngoSeptemba 25, 2016 ukuya kwi-26 Septemba 2020, ukufumanisa impembelelo ye-COVID-19 bhubhane kwinani lomhlaza omtsha. amatyala achongiwe. Bafumene abaguli abadala abangama-358,487 babenomhlaza omtsha ofunyenweyo ngelo xesha. Izinga leveki neveki lokuxilonga lizinzile phambi kobhubhani, kodwa lehle nge-34.3% ngoMatshi ka-2020. Emva koko, kukho umkhwa wokunyuka kwe-1% kuxilongo olutsha rhoqo ngeveki kulo lonke ixesha lokufunda.

"Idatha yethu ibonisa ukuba uninzi lomhlaza alubonwanga ngenxa yokuphazamiseka kwenkqubo yezempilo ekuphenduleni ubhubhane we-COVID-19," ucacise watsho u-Antoine Eskander, MD, ScM, ICES, Toronto, Ontario. “Oku kuyakhathaza kuba ukulibaziseka kokuxilongwa komhlaza kunxulunyaniswa nethuba elisezantsi lokunyangeka. Ababoneleli ngezempilo kufuneka bakhuthaze izigulana ukuba zijonge umhlaza wazo ukuba kukho naziphi na eziye zaphoswa ngexesha lobhubhane, kwaye kufuneka zisebenzise umda ophantsi ukuphanda izigulana nazo naziphi na iimpawu ezingaqhelekanga ezinokunxulumana nomhlaza ongafunyaniswanga. ”

Ukuhla koxilongo olutsha kwafunyanwa kuzo zombini ii-cancer zokuhlola-ezo zineenkqubo zokuhlola ezisesikweni ezifana nomhlaza womlomo wesibeleko, umhlaza webele kunye nomhlaza we-colorectal (kwaye ngamanye amaxesha umhlaza wemiphunga) - kunye nomhlaza ongajongiyo. Abaphandi baqikelela malunga ne-12,600 yomhlaza engakhange ibonwe phakathi kwe-15 kaMatshi kunye ne-26 kaSeptemba 2020. Olona kuncipha lukhulu kuxilongo lufunyenwe kwi-melanoma, umlomo wesibeleko, i-endocrine, kunye nomhlaza we-prostate.

"Ubhubhane ubangele utshintsho olukhulu kwinkqubo yokhathalelo lwempilo, kubandakanya ukwehla okuxhalabisayo ekuhlolweni komhlaza," utshilo uHarold Burstein, MD, PhD, Dana-Farber Cancer Institute, owayengabandakanyekanga kolu phando. “Olu phononongo yingxelo eyenziwe kakuhle evela e-Ontario, eCanada, apho zikhoyo iirekhodi zephondo ngokubanzi, kwaye lubonisa ukwehla okukhulu ekuhlolweni kwe-colorectal (colonoscopy), umlomo wesibeleko (Pap smear), kunye nomhlaza wamabele (mammogram) ekuqaleni. iinyanga zobhubhane. Iziphumo ezifanayo ziye zaxelwa kumaziko ezempilo aphambili kuwo wonke uMntla Merika, eYurophu nakwamanye amazwe aneenkqubo zovavanyo ezixhaphakileyo.”

UGqr. Burstein-ilungu leNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panel for Breast Cancer-yaqhubeka: "Nangona ubhubhane, kubalulekile ukuba abantu baqhubeke befumana ukuhlolwa okucetyiswayo komhlaza. Ngemiqathango ye-COVID ebekwe ziikliniki, kukhuseleke kakhulu ukuba abantu babone iqela labo lezonyango kwiimammograms zesiqhelo, i-pap smears, kunye nolunye uvavanyo olubalulekileyo. Ngethamsanqa, apha eBoston nakwamanye amaziko amaninzi, amanani ethu ovavanyo lwemammograms achacha ngokukhawuleza emva kokuphola ngo-2020, kwaye senza konke esinako ukukhumbuza abantu ngokubaluleka kovavanyo rhoqo. ”

I-NCCN iphinde idibanise namaqela omhlaza kulo lonke ilizwe ukwabelana ngolwazi malunga nokubaluleka kunye nokhuseleko lokuhlolwa komhlaza.

INTO ONOKUYITHATHA KWELI NQAKU:

“This study is a well done report from Ontario, Canada, where province-wide records are available, and it shows a huge decline in screening for colorectal (colonoscopy), cervical (Pap smear), and breast cancer (mammogram) in the early months of the pandemic.
Research in the March 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network examined data from the Ontario Cancer Registry from September 25, 2016 through September 26, 2020, to determine the impact of the COVID-19 pandemic on the number of new cancer cases detected.
Fortunately, here in Boston and many other centers, our numbers of screening mammograms are recovering rapidly after the lull in 2020, and we are doing all we can to remind people of the importance of regular screening.